Arena Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 65 U.S.-traded ETFs. ARNA has around 4.9M shares in the U.S. ETF market. The largest ETF holder of ARNA is the iShares Russell 2000 ETF (IWM), with approximately 1.08M shares. Investors may also find of interest that the ETF with the largest allocation to ARNA stock is AdvisorShares Pure Cannabis ETF (YOLO), with a portfolio weight of 4.33%. On average, U.S. ETFs allocate 0.53% of ARNA to their portfolios.
Additionally, ARNA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ARNA as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 45.02%.